Skip to Content

Disclaimer

Disclaimer
MDS makes every effort to publish accurate information on the website. "Google Translate" is provided as a free tool for visitors to read content in one's native language. Translations are not guaranteed to be 100% accurate. Neither MDS nor its employees assume liability for erroneous translations of website content.

Congress
Main Content

Parallel Session 3407

The Role of a-synuclein and Other Proteins in Parkinson’s Disease Pathogenesis

Tuesday, October 7, 2025
16:30 - 18:00 | Room TBD
Basic Science, Translational

In this session, the faculty will discuss the molecular pathomechanisms and the spectrum of proteins involved in Parkinson’s disease, as well as the implications for clinical trials.


Chairs:
Gabor Kovacs, Canada
Per Svenningsson, Sweden

Presenters:

A-Synuclein Prion Strains in Parkinson's Disease Pathogenesis, Phenotype, and Progression
Ayami Okuzumi, Japan

Proteins Beyond A-synuclein: Bystanders or Real Partners?
Zane Jaunmuktane, United Kingdom

Clinical Implications of Co-pathologies
Bradley Boeve, USA

CSPC Liaisons:
Gabor Kovacs, Canada

Learning Objectives
At the conclusion of this session, participants should be better able to:

  1. Interpret the role of a-synuclein prion strains in the pathogenesis, phenotypic spectrum and disease progression in Parkinson’s disease
  2. Recognize the spectrum of proteins involved beyond a-synuclein in the pathogenesis of Parkinson’s disease
  3. Interpret the relevance of mixed pathologies in patient selection and clinical trial design

Recommended Audience
Clinician / General Neurology
Fellow / Resident / Student
Industry
Researcher / Basic Science

Education Level
Advanced / Expert
Intermediate / Experienced

We use cookies to give you the best possible experience with our website. These cookies are also used to ensure we show you content that is relevant to you. If you continue without changing your settings, you are agreeing to our use of cookies to improve your user experience. You can click the cookie settings link on our website to change your cookie settings at any time. Note: The MDS site uses related multiple domains, including mds.movementdisorders.org and mds.execinc.com. This cookie policy only covers the primary movementdisorders.org and mdscongress.org domain. Please refer to the MDS Privacy Policy for information on how to configure cookies for all other domains on the MDS site.
Cookie PolicyPrivacy Notice